Literature DB >> 31980225

Exposure to chronic light-dark phase shifts during the prepartum nonlactating period attenuates circadian rhythms, decreases blood glucose, and increases milk yield in the subsequent lactation.

Aridany Suarez-Trujillo1, Grace Wernert1, Hui Sun2, Tabitha S Steckler1, Katelyn Huff1, Shelby Cummings1, Jackeline Franco3, Rebecca N Klopp1, Jonathan R Townsend4, Michael Grott5, Jay S Johnson6, Karen Plaut1, Jacquelyn P Boerman1, Theresa M Casey7.   

Abstract

Maintaining metabolic balance is a key factor in the health of dairy cattle during the transition from pregnancy to lactation. Little is known regarding the role of the circadian timing system in the regulation of physiological changes during the transition period. We hypothesized that disruption of the cow's circadian timing system by exposure to chronic light-dark phase shifts during the prepartum period would negatively affect the regulation of homeostasis and cause metabolic disturbances, leading to reduced milk production in the subsequent lactation. The objective was to determine the effect of exposure to chronic light-dark phase shift during the last 5 wk prepartum of the nonlactating dry period on core body temperature, melatonin, blood glucose, β-hydroxybutyric acid (BHB) and nonesterified fatty acid (NEFA) concentrations, and milk production. Multiparous cows were moved to tiestalls at 5 wk before expected calving and assigned to control (CTR; n = 16) or phase-shifted (PS; n = 16) treatments. Control cows were exposed to 16 h of light and 8 h of dark. Phase-shifted cows were exposed to the same photoperiod; however, the light-dark cycle was shifted 6 h every 3 d until parturition. Resting behavior and feed intake were recorded daily. Core body temperature was recorded vaginally for 48 h at 23 and 9 d before expected calving using calibrated data loggers. Blood concentrations of melatonin, glucose, BHB, and NEFA were measured during the pre- and postpartum periods. Milk yield and composition were measured through 60 DIM. Treatment did not affect feed intake or body condition. Cosine fit analysis of 24-h core body temperature and circulating melatonin indicated attenuation of circadian rhythms in the PS treatment compared with the CTR treatment. Phase-shifted cows had lower rest consolidation, as indicated by more total resting time, but shorter resting period durations. Phase-shifted cows had lower blood glucose concentration compared with CTR cows (4 mg/mL decrease), but BHB and NEFA concentrations were similar between PS and CTR cows. Milk yield and milk fat yield were greater in PS compared with CTR cows (2.8 kg/d increase). Thus, exposure to chronic light-dark phase shifts during the prepartum period attenuated circadian rhythms of core body temperature, melatonin, and rest-activity behavior and was associated with increased milk fat and milk yield in the postpartum period despite decreased blood glucose pre- and postpartum. Therefore, less variation in central circadian rhythms may create a more constant milieu that supports the onset of lactogenesis.
Copyright © 2020 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood glucose; circadian rhythm; nonesterified fatty acid; nonlactating period; transition period

Mesh:

Substances:

Year:  2020        PMID: 31980225     DOI: 10.3168/jds.2019-16980

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  2 in total

Review 1.  Circadian clocks and their integration with metabolic and reproductive systems: our current understanding and its application to the management of dairy cows.

Authors:  Theresa M Casey; Karen Plaut
Journal:  J Anim Sci       Date:  2022-10-01       Impact factor: 3.338

2.  Effects of achromatic and chromatic lights on pupillary response, endocrinology, activity, and milk production in dairy cows.

Authors:  Sofia Lindkvist; Emma Ternman; Sabine Ferneborg; Daniel Bånkestad; Johan Lindqvist; Björn Ekesten; Sigrid Agenäs
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.